{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T23:22:45Z","timestamp":1745968965996},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,17]]},"DOI":"10.7759\/cureus.33893","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T19:38:05Z","timestamp":1673984285000},"source":"Crossref","is-referenced-by-count":2,"title":["Analysis of Biochemical and Inflammatory Markers for Predicting COVID-19 Severity: Insights From a Tertiary Healthcare Institution of Eastern India"],"prefix":"10.7759","author":[{"given":"Suchitra","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurav","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swagata","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourin","family":"Bhuniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manaswini","family":"Mangaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balamurugan","family":"Ramadass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchanda","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debapriya","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakruti","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautom K","family":"Saharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105948","article-title":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence","volume":"55","author":"Wang L","year":"2020","unstructured":"Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020, 55:105948. 10.1016\/j.ijantimicag.2020.105948","journal-title":"Int J Antimicrob Agents"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai CC","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020, 55:105924. 10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan Y","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020, 94:10.1128\/JVI.00127-20","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05242-w","article-title":"Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study","volume":"20","author":"Wang D","year":"2020","unstructured":"Wang D, Li R, Wang J, et al.. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infect Dis. 2020, 20:519. 10.1186\/s12879-020-05242-w","journal-title":"BMC Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa152","article-title":"Analysis of mortality in patients with COVID-19: clinical and laboratory parameters","volume":"7","author":"Tian S","year":"2020","unstructured":"Tian S, Liu H, Liao M, et al.. Analysis of mortality in patients with COVID-19: clinical and laboratory parameters. Open Forum Infect Dis. 2020, 7:ofaa152. 10.1093\/ofid\/ofaa152","journal-title":"Open Forum Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li G","year":"2020","unstructured":"Li G, Fan Y, Lai Y, et al.. Coronavirus infections and immune responses. J Med Virol. 2020, 92:424-32. 10.1002\/jmv.25685","journal-title":"J Med Virol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China","volume":"214","author":"Zhang W","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, et al.. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020, 214:108393. 10.1016\/j.clim.2020.108393","journal-title":"Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti P","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga CE, Ross R, Frydas I, Kritas SK. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020, 34:327-31. 10.23812\/CONTI-E","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.23812\/20-Editorial-Kritas","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","volume":"34","author":"Kritas SK","year":"2020","unstructured":"Kritas SK, Ronconi G, Caraffa A, Gallenga CE, Ross R, Conti P. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2020, 34:9-14. 10.23812\/20-Editorial-Kritas","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003568","article-title":"A neutrophil activation signature predicts critical illness and mortality in COVID-19","volume":"5","author":"Meizlish ML","year":"2021","unstructured":"Meizlish ML, Pine AB, Bishai JD, et al.. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021, 5:1164-77. 10.1182\/bloodadvances.2020003568","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77525-w","article-title":"Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19","volume":"10","author":"Haljasm\u00e4gi L","year":"2020","unstructured":"Haljasm\u00e4gi L, Salumets A, Rumm AP, et al.. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19. Sci Rep. 2020, 10:20533. 10.1038\/s41598-020-77525-w","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.19.20034447","article-title":"Potential biochemical markers to identify severe cases among COVID-19 patients","author":"Xiang J","year":"2020","unstructured":"Xiang J, Wen J, Yuan X, Xiong S, Zhou X, Liu C, Min X. Potential biochemical markers to identify severe cases among COVID-19 patients. Epidemiology. 2020, 10.1101\/2020.03.19.20034447","journal-title":"Epidemiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.10.007","article-title":"Prognostic value of liver biochemical parameters for COVID-19 mortality","volume":"21","author":"Ye L","year":"2021","unstructured":"Ye L, Chen B, Wang Y, et al.. Prognostic value of liver biochemical parameters for COVID-19 mortality. Ann Hepatol. 2021, 21:100279. 10.1016\/j.aohep.2020.10.007","journal-title":"Ann Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.05.055","article-title":"Association of inflammatory markers with the severity of COVID-19: a meta-analysis","volume":"96","author":"Zeng F","year":"2020","unstructured":"Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020, 96:467-74. 10.1016\/j.ijid.2020.05.055","journal-title":"Int J Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-81. 10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/lmaa015","article-title":"Soluble CD14 subtype in peripheral blood is a biomarker for early diagnosis of sepsis","volume":"51","author":"Zhou W","year":"2020","unstructured":"Zhou W, Rao H, Ding Q, Lou X, Shen J, Ye B, Xiang C. Soluble CD14 subtype in peripheral blood is a biomarker for early diagnosis of sepsis. Lab Med. 2020, 51:614-9. 10.1093\/labmed\/lmaa015","journal-title":"Lab Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041295","article-title":"Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study","volume":"10","author":"Hodges G","year":"2020","unstructured":"Hodges G, Pallisgaard J, Schjerning Olsen AM, et al.. Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study. BMJ Open. 2020, 10:e041295. 10.1136\/bmjopen-2020-041295","journal-title":"BMJ Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 severity: a literature review","volume":"31","author":"Gallo Marin B","year":"2021","unstructured":"Gallo Marin B, Aghagoli G, Lavine K, et al.. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021, 31:1-10. 10.1002\/rmv.2146","journal-title":"Rev Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117788","article-title":"The role of biomarkers in diagnosis of COVID-19 - a systematic review","volume":"254","author":"Kermali M","year":"2020","unstructured":"Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 - a systematic review. Life Sci. 2020, 254:117788. 10.1016\/j.lfs.2020.117788","journal-title":"Life Sci"},{"key":"ref23","unstructured":"CDC. Symptoms of COVID-19. (2020). Accessed: December 30, 2022: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.003","article-title":"Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China","volume":"146","author":"Chen R","year":"2020","unstructured":"Chen R, Sang L, Jiang M, et al.. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020, 146:89-100. 10.1016\/j.jaci.2020.05.003","journal-title":"J Allergy Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle DM","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang HH, et al.. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020, 26:1636-43. 10.1038\/s41591-020-1051-9","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/1724600819874487","article-title":"Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: a meta-analysis","volume":"34","author":"Zeng F","year":"2019","unstructured":"Zeng F, Chen B, Zeng J, Wang Z, Xiao L, Deng G. Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: a meta-analysis. Int J Biol Markers. 2019, 34:213-20. 10.1177\/1724600819874487","journal-title":"Int J Biol Markers"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31326","article-title":"Liver biochemistries in hospitalized patients with COVID-19","volume":"73","author":"Bloom PP","year":"2021","unstructured":"Bloom PP, Meyerowitz EA, Reinus Z, et al.. Liver biochemistries in hospitalized patients with COVID-19. Hepatology. 2021, 73:890-900. 10.1002\/hep.31326","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.13.20099614","article-title":"Dynamic liver function indexes monitoring and clinical characteristics in three types of COVID-19 patients","author":"Chen C","year":"2020","unstructured":"Chen C, Jiang J, Xu X, Hu Y, Hu Y, Zhao Y. Dynamic liver function indexes monitoring and clinical characteristics in three types of COVID-19 patients. Gastroenterology. 2020, 10.1101\/2020.05.13.20099614","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1039\/d0lc00373e","article-title":"Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19","volume":"20","author":"McRae MP","year":"2020","unstructured":"McRae MP, Simmons GW, Christodoulides NJ, et al.. Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19. Lab Chip. 2020, 20:2075-85. 10.1039\/d0lc00373e","journal-title":"Lab Chip"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132332-analysis-of-biochemical-and-inflammatory-markers-for-predicting-covid-19-severity-insights-from-a-tertiary-healthcare-institution-of-eastern-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:38Z","timestamp":1707508118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132332-analysis-of-biochemical-and-inflammatory-markers-for-predicting-covid-19-severity-insights-from-a-tertiary-healthcare-institution-of-eastern-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.33893","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}